Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 15/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.36 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL28881877 | 0.76 | FDPS (0.46) | FDPSLMNAGGPS1LPAR1LPAR3 | |
| SCHEMBL19211961 | 0.75 | FDPS (0.59) | FDPSLMNAGGPS1SMPD1LPAR1 | |
| Methyl Phosphonate SCHEMBL11412790 | 0.73 | CA2 (0.53) | FDPSLMNAGGPS1SMPD1LPAR1 | |
| SCHEMBL8718782 | 0.73 | GGPS1 (0.50) | FDPSLMNAGGPS1SMPD1LPAR1 | |
| SCHEMBL246809 | 0.73 | FDPS (0.43) | FDPSLMNAGGPS1SMPD1LPAR1 | |
| SCHEMBL6296955 | 0.73 | FDPS (0.43) | FDPSLMNAGGPS1SMPD1LPAR1 | |
| SCHEMBL6227455 | 0.71 | FDPS (0.46) | FDPSLMNAGGPS1SMPD1 | |
| SCHEMBL12473686 | 0.71 | FDPS (0.37) | FDPSLMNAGGPS1 | |
| SCHEMBL252754 | 0.71 | FDPS (0.48) | FDPSLMNAGGPS1 | |
| SCHEMBL10773437 | 0.71 | FDPS (0.48) | FDPSLMNAGGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3413934-B1 | IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS | NANO BRIDGING MOLECULES SA (CH) | 2021-10-13 | — | — | EP | claimed |
| CN-109195641-B | Improved implant treatment with phosphonic acid compounds | 纳米桥接分子股份公司 | 2021-07-27 | — | — | CN | claimed |
| US-11000627-B2 | Treatment of implants with phosphonic acid compounds | NANO BRIDGING MOLECULES SA (CH) | 2021-05-11 | — | — | US | claimed |
| US-20190038802-A1 | IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS | NANO BRIDGING MOLECULES SA (CH) | 2019-02-07 | — | — | US | claimed |
| EP-3413934-A1 | IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS | Nano Bridging Molecules SA (CH) | 2018-12-19 | — | — | EP | claimed |
| WO-2017137623-A1 | IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS | NANO BRIDGING MOLECULES SA (CH) | 2017-08-17 | — | — | WO | claimed |
| EP-4385499-A1 | A METHOD TO ENABLE NANOPARTICLES STORED WITH A SPECIFIC TYPE OF ASSEMBLY TO MAINTAIN THIS TYPE OF ASSEMBLY UPON RECONSTITUTION | Nanobacterie (FR) | 2024-06-19 | — | — | EP | disclosed |
| CN-118078774-A | Method enabling nanoparticles stored under a specific type of assembly to maintain this type of assembly after reconstitution | 纳米细菌公司 | 2024-05-28 | — | — | CN | disclosed |
| US-20240165234-A1 | METHOD TO ENABLE NANOPARTICLES STORED WITH A SPECIFIC TYPE OF ASSEMBLY TO MAINTAIN THIS TYPE OF ASSEMBLY UPON RECONSTITUTION | NANOBACTERIE (FR) | 2024-05-23 | — | — | US | disclosed |
| EP-4371574-A1 | IRON OXIDE NANOPARTICLES COMPRISING TWO CENTERS OF ACTIVITIES OR FREE RADICAL CAPTURE/PRODUCTION FOR AN ENHANCED ACTIVITY | Nanobacterie (FR) | 2024-05-22 | — | — | EP | disclosed |
| EP-4371575-A1 | COMBINING SPATIAL AND TEMPORAL SEQUENCES OF IRRADIATION USING A SPECIFIC NANO-SYSTEM FOR AN IMPROVED TREATMENT OF DISEASES SUCH AS CANCER | Nanobacterie (FR) | 2024-05-22 | — | — | EP | disclosed |
| US-20240156745-A1 | IRON OXIDE NANOPARTICLES COMPRISING TWO CENTERS OF ACTIVITIES OR FREE RADICAL CAPTURE/PRODUCTION FOR AN ENHANCED ACTIVITY AND COMBINING SPATIAL AND TEMPORAL SEQUENCES OF IRRADIATION USING THE NANOPARTICLES FOR AN IMPROVED TREATMENT OF DISEASES | NANOBACTERIE (FR) | 2024-05-16 | — | — | US | disclosed |
| EP-3413934-B1 | IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS | NANO BRIDGING MOLECULES SA (CH) | 2021-10-13 | — | — | EP | disclosed |
| EP-2370085-B1 | TREATMENT OF CANCER OR TUMOR INDUCED BY THE RELEASE OF HEAT GENERATED BY VARIOUS CHAINS OF MAGNETOSOMES EXTRACTED FROM MAGNETOTACTIC BACTERIA AND SUBMITTED TO AN ALTERNATIVE MAGNETIC FIELD | NANOBACTERIE (FR) | 2015-04-15 | — | — | EP | disclosed |
| EP-2852371-A2 | COSMETIC COMPOSITIONS COMPRISING MAGNETOSOMES AND USES THEREOF | Natura Bisse International, S.A. (ES) | 2015-04-01 | — | — | EP | disclosed |
| WO-2013174774-A2 | COSMETIC COMPOSITIONS COMPRISING MAGNETOSOMES AND USES THEREOF | NATURA BISSÉ INTERNATIONAL S.A. (ES) | 2013-11-28 | — | — | WO | disclosed |
| EP-2666456-A1 | Cometic compositions comprising magnetosomes and uses thereof | Natura Bisse International, S.A. (ES) | 2013-11-27 | — | — | EP | disclosed |
| US-20120302819-A1 | TREATMENT OF CANCER OR TUMORS INDUCED BY THE RELEASE OF HEAT GENERATED BY VARIOUS CHAINS OF MAGNETOSOMES EXTRACTED FROM MAGNETOTACTIC BACTERIA AND SUBMITTED TO AN ALTERNATIVE MAGNETIC FIELD | NANOBACTERIE | 2012-11-29 | — | — | US | disclosed |
| EP-2370085-A1 | TREATMENT OF CANCER OR TUMOR INDUCED BY THE RELEASE OF HEAT GENERATED BY VARIOUS CHAINS OF MAGNETOSOMES EXTRACTED FROM MAGNETOTACTIC BACTERIA AND SUBMITTED TO AN ALTERNATIVE MAGNETIC FIELD | Nanobacterie (FR) | 2011-10-05 | — | — | EP | disclosed |
| WO-2011061259-A1 | TREATMENT OF CANCER OR TUMOR INDUCED BY THE RELEASE OF HEAT GENERATED BY VARIOUS CHAINS OF MAGNETOSOMES EXTRACTED FROM MAGNETOTACTIC BACTERIA AND SUBMITTED TO AN ALTERNATIVE MAGNETIC FIELD | NANOBACTERIE (FR) | 2011-05-26 | — | — | WO | disclosed |